Gene Query: STARD13

Dataset Description Geneva Score
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 44.63
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 35.93
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 29.29
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 28.92
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 23.9
Gene expression in PANC1 cells treated with Rakicidin 22.41
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 21.29
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 20.35
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 19.32
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 19.25
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 18.61
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 17.93
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 17.88
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 17.74
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 17.18
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 16.79
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 16.36
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 16.32
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 16.32
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 16.13
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 16.13
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 15.88
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 15.62
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 14.61
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 14.44
Differential Gene Expression between MCF10A and MCF7 cells 14.1
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 14.08
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 13.97
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 13.91
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 13.85
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 13.75
Integrin signaling regulates YAP/TAZ to control skin homeostasis 13.22
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 13.15
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 12.98
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 12.98
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 12.84
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 12.59
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 12.59
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 12.59
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 12.59
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 12.36
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 12.09
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 12.09
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 11.95
NR2F2 study 11.95
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 11.88
Universal alternative splicing of noncoding exons 11.73
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 11.65
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 11.34
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 11.34
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 11.32
Selective expression of long non-coding RNAs in a breast cancer cell progression model 11.27
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 11.18
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 10.94
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 10.94
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 10.86
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 10.67
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 10.67
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 10.53
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 10.31
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 10.29
AUF-1 affected genes in human skin cells 9.96
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.76
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 9.73
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 9.68
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 9.65
Differential expression of genes in AD169-infected MRC5. 9.63
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 9.58
Differential gene expression in Jagged1 treated human dental pulp cells. 9.57
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.56
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.51
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 9.46
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 9.45
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 9.39
UV_24h_GRO-Seq 9.27
Survival of pancreatic cancer cells lacking KRAS function 9.13
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.01
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.01
4sU-seq of HFF exposed to salt and heat stress 8.96
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.89
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.8
PGE2 mediated gene expression changes in human cervical stromal cells 8.74
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.64
Transcriptomic analyssis following EHMT1/2 inhibition 8.39
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 8.38
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 8.36
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 8.36
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.36
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.36
RNA-sequencing of formalin fixed human primary melanoma tissue 8.33
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 8.29
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 8.26
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 8.01
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 8.01
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 8.0
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 7.8
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.78
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.78
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 7.72
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.69
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 7.68
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 7.68
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 7.65
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 7.59
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 7.53
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.53
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 7.53
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 7.52
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 7.51
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 7.48
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 7.36
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 7.23
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 7.23
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 7.2
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 7.14
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 7.14
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 7.13
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.12
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 7.08
RNA-seq of young and quiescent MRC-5 human fibroblasts 7.04
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 6.88
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 6.87
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 6.79
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 6.79
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.76
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.76
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 6.65
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 6.62
Silencing SPIB in attached and floating state of H1703 lung cancer cells 6.62
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 6.6
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 6.6
Selective suppression of endothelial cytokine production by progesterone receptor 6.6
Regulation of Lipids is Central to Replicative Senescence 6.57
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 6.5
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 6.48
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 6.48
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 6.46
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 6.46
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.45
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 6.43
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 6.34
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 6.33
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 6.33
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 6.29
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 6.28
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 6.28
Toxoplasma gondii infection of human retinal pigment epithelial cells 6.19
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 6.19
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 6.16
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 6.11
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.11
Genome-wide transcriptional response to random aneuploidy in human cells 6.09
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.07
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 6.05
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 6.04
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 5.99
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.96
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 5.95
DRB/GRO-Seq -/+ UV 5.85
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 5.81
Genome-wide Analysis of Chromatin Interactions in Human Cells 5.81
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 5.8
Silencing p300 in MCF7 cells to study expression and alternative splicing 5.78
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.75
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 5.74
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 5.74
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 5.73
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 5.73
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 5.71
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 5.7
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.67
Functional role of SLIT2 and ROBO1 in trophoblasts 5.65
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 5.63
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 5.63
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 5.59
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 5.57
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 5.56
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 5.56
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 5.55
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 5.55
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 5.54
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 5.53
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.5
Gene expression profile in breast cancer cells 5.5
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 5.5
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 5.5
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 5.48
Downregulation of LATS kinases alters p53 to promote cell migration 5.39
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 5.38
High level DNA repair gene expression in human ES cells 5.35
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 5.33
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.3
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.3
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 5.26
Transcriptional responses of melanoma cells to BRAF inhibition 5.25
The evolution of N6-methyladenosine in primates 5.25
X-Ray induced DNA-Hydroxymethylation changes 5.23
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.2
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.2
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 5.19
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 5.19
IRF1 regulates IFN dependent and independent gene expression 5.19
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 5.19
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 5.18
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 5.16
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 5.15
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 5.15
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.15
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 5.11
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 5.11
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 5.09
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 5.09
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 5.06
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.0
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.99
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 4.98
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  4.96
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 4.95
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.95
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.95
Chromatin landscape of human visceral and subcutaneous adipocytes 4.92
The role of CFTR in islet function 4.92
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 4.85
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 4.83
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.82
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.75
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 4.74
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.72
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 4.71
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 4.71
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 4.71
High-efficiency RNA-based reprogramming of human primary fibroblasts 4.67
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 4.63
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 4.63
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 4.61
Transciptomic profiling of human fetal lung samples 4.58
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 4.57
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 4.55
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.54
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 4.53
RNA-seq of human fibroblasts after irradiation 4.53
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 4.52
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 4.51
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 4.47
RNA editing in nascent RNA affects pre-mRNA splicing 4.46
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 4.46
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 4.46
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.46
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 4.43
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 4.43
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 4.43
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 4.43
MicroRNA targetome analysis during HCMV infection 4.43
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 4.42
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 4.37
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 4.37
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 4.36
Nonpregnant and term pregnant human myometrial tissues 4.36
Differentially expressed genes post knock down of lincDUSP26 4.36
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.34
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.33
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 4.33
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 4.33
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 4.32
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 4.32
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 4.3
Direct Isolation and Characterization of Human Nephron Progenitors. 4.28
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 4.27
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.22
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 4.22
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 4.22
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 4.2
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 4.2
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 4.19
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.17
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.17
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.17
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 4.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.16
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.16
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 4.15
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 4.15
STX4 Over-Expression in Human islets 4.09
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 4.07
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.07
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 4.07
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 4.07
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 3.99
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.96
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.95
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 3.94
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 3.9
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 3.88
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 3.88
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 3.86
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 3.85
FOXP1 orchestration of ASD-relevant signaling pathways. 3.81
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.75
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 3.72
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.71
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 3.7
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 3.7
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.68
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 3.6
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 3.59
Primate transcript and protein expression levels evolve under compensatory selection pressures 3.58
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.52
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 3.5
Generation of trichogenic adipose-derived stem cells by expression of three factors 3.47
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.44
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 3.42
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 3.4
Transcriptomic analysis of LSD1 3.4
Transcriptome analysis reveals differential splicing events in IPF lung tissue 3.36
RNA-seq of MCF10A cells and CAF 3.36
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.35
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.35
Gene expression profile difference among renal location in a stone former 3.33
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.32
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.32
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.32
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.32
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 3.31
HEXIM1 is induced by DHODH inhibition to suppress melanoma 3.31
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.29
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 3.26
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 3.25
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 3.23
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.21
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.2
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 3.19
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.12
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 3.12
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 3.11
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.09
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.08
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.08
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 3.08
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.02
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 3.01
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 3.01
CHD1 regulates cell fate determination by activation of differentiation-induced genes 3.0
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 2.98
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 2.91
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.85
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.85
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.81
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 2.77
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 2.76
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.75
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.75
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 2.73
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 2.7
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 2.7
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 2.69
Ro60-knockout cells 2.69
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.68
RNA-seq melanoma 2.66
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 2.56
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 2.56
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.53
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 2.5
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 2.49
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 2.47
Human ovarian granulosa cell transcriptome 2.44
The Genomic Landscape of Atypical Fibroxanthoma 2.42
iPSC-Derived Cholangiocytes 2.38
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 2.31
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.3
Proteomics identifies a marker signature of MAPKi resistance in melanoma 2.28
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.26
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.25
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.22
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.22
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.2
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 2.19
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 2.19
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.16
Differential gene expression of human melanoma cells [RNA-seq] 2.16
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.16
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.16
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 2.15
Redifferentiation of expanded human islet β cells by inhibition of ARX 2.15
The human blood-nerve barrier transcriptome 2.1
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.06
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.04
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.03
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 2.0
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.94
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 1.91
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.9
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.86
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.83
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.83
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 1.82
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.81
RNA-sequencing 1.79
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 1.78
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.78
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 1.73
Random mono-allelic expression in MECP2-mutated cells 1.71
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.7
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.7
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.7
JAK dependent survival of ALK- ALCL 1.69
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.68
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.65
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.58
Transcriptome of human white and brown adipose tissue biopsies 1.58
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.57
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 1.54
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.49
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.49
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.48
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.47
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 1.44
Identification of the role of polydom in neurofibromas 1.43
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.33
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.31
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.3
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.29
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.26
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.22
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 1.2
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 1.2
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.15
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.15
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.11
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 1.1
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 1.03
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.03
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 1.02
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.0
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.97
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.9
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.9
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.9
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.9
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.9
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.88
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.87
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.85
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.83
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.83
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.83
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.82
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.82
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.76
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.73
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.72
Effects of transcription on genome - nuclear lamina interactions 0.72
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.71
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 0.69
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.69
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.66
KSDM1b Role in Ewing Sarcoma 0.61
Transcriptomes in healthy and CHB fetal hearts 0.55
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 0.54
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.54
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.54
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.52
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 0.51
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.5
EGR1-controlled transcriptome of T HESCs 0.49
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 0.45
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 0.42
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.41
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.41
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.41
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.4
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.4
A code of mono-phosphorylation modulates the function of RB. 0.39
PTHrP overexpression in MCF7 cells 0.39
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.37
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.37
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 0.36
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.36
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.36
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.33
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.31
Active translatome profiling with RiboLace in MCF7 cells 0.3
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 0.26
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.24
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.2
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 0.19
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.19
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.17
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 0.16
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 0.16
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.15
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.11
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.11
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.09
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.09
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.09
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.07
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.07
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 0.04
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation